Kitta, Takeya <br/><br/>
Editorial Comment to Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).  [electronic resource] 

 -  International journal of urology : official journal of the Japanese Urological Association  03 2019 
 - 352 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1442-2042 
<br/><br/><label>Standard No.: </label>10.1111/iju.13862  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetanilides<br/>Humans<br/>Japan<br/>Muscarinic Antagonists<br/>Thiazoles<br/>Urinary Bladder, Overactive